Wordt geladen...
Does estrogen play a role in response to adjuvant bone-targeted therapies?
Bone remains the most common site of breast cancer recurrence. The results of population studies, pre-clinical research and clinical studies in patients with metastatic disease provided a rationale for testing bone-targeted agents in the adjuvant setting. Despite the initial optimism, results from e...
Bewaard in:
| Gepubliceerd in: | J Bone Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4723380/ https://ncbi.nlm.nih.gov/pubmed/26909288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2013.06.001 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|